Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TREANDA | 100MG | POWDER FOR SOLUTION | Resolved | 2024-11-28 | 2025-05-02 | 244075 |
| TRISENOX | 1MG | SOLUTION | Resolved | 2017-07-14 | 2018-07-30 | 15753 |
| TRISENOX | 10MG | SOLUTION | Actual shortage | 2020-05-14 | 2022-06-03 | 115216 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-10 | 92198 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-01-27 | 98185 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2020-03-12 | 2020-08-27 | 108601 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2020-11-06 | 2021-01-07 | 128028 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2024-12-10 | 2025-04-24 | 245304 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-02-21 | 98179 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-28 | 2020-06-25 | 99955 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-02-21 | 2020-04-09 | 106925 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-04-23 | 2020-08-27 | 113031 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-08-06 | 2020-11-07 | 121865 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144448 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144451 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Avoided shortage | 2021-08-23 | 2021-08-23 | 144454 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144494 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144497 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2024-12-20 | 2025-10-23 | 246267 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2025-01-30 | 2025-04-24 | 249198 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |